Analyst Ratings for Panbella Therapeutics (PBLA)

PBLA Rating Summary

  |   Expand Research on PBLA
Overall Rating: BUY   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 6.7 / 10   Percentile Rank: 71%
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
5/16/2024 H.C. Wainwright Joseph Pantginis Downgrade Neutral
(Buy)		 N/A
(N/A)		 1.11
(0.01)		 -99.1% Details
3/20/2023 Maxim Group Jason McCarthy Upgrade Buy
(Hold)		 1.50
(N/A)		 0.51
(0.01)		 -98.04% Details